Manufacturing

Experts from Umoja Biopharma dive into cell therapy development in this episode of the Drug Solutions Podcast, including the greatest advancements in cell therapy to date, areas for improvement, the biggest trends in cell therapy development, and retention as a pain point.

Civica is expanding in the greater Richmond-Petersburg region and investing $27.8 million in a new testing facility.

Automation enables intensification of downstream processes.

Rapidly growing industry must overcome supply chain constraints.

MilliporeSigma’s €130 million (USD$132 million) investment is designed to increase manufacturing capacity of single-use assemblies.

Charles River Laboratories and Cure AP-4 will collaborate on gene therapy manufacturing for AP-4 hereditary spastic paraplegia.

A new survey has demonstrated that remote audits, brought to the fore thanks to COVID-19, are not necessarily a preferred option for clients.

Hovione has expanded its drug product offering with a new manufacturing line dedicated to continuous tableting.

Biopharmaceutical manufacturers must consider a surprisingly wide range of factors when deciding where to turn for assistance with cell line development.

Expanded use of data analytics can help to avoid disruptions, but the possibilities cannot be realized without sufficient investment and direct human involvement.

Cleanroom monitoring may be in a state of flux after many recent technological advancements.

By eliminating the waste involved in traditional approaches to project set-up and execution, integrated project delivery helps innovators in the European life sciences market meet their fast-track delivery targets.

More than anything else MonkeyPox and COVID-19 have shown that we are interdependent, no matter what continent you call home.

The ROSS Vertical Blender enables mixing of friable solids.

Shimadzu’s Nexera XS inert is designed to prevent both adsorption of target molecules to metal surfaces and mobile-phase corrosion.

Cellefill is a vial fill/finish system that designed to promote flexibility via an integrated barrier solutions.

Qosina’s AseptiQuik STC Series enables flexibility between hybrid stainless steel and single-use processing equipment.

Pharmaceutical Technology editors interview aseptic and sterilization experts from Watson-Marlow Fluid Technology Solutions and Cherwell—diving into sterilization, aseptic processing, and the revised EU GMP Annex 1 guidance.

Forecyte Bio and Cytiva will team up to accelerate the development and manufacturing of cell and gene therapies.

Thermo Fisher Scientific’s new 300,000 ft² facility, located in Plainville, Mass., will specialize in manufacturing viral vectors.

Watson-Marlow and Franz Ziel GmbH have launched a new integrated solution to fast-track cell, gene, and biological therapies.

ChargePoint Technology has acquired single-use container company PuroVaso.

Grand River Aseptic Manufacturing has completed phase II of its facility expansion with the installation of two new sterile filling lines.

ProBioGen will collobarate with NextPoint Therapeutics to develop and manufacture its lead antibody candidate.

Validair Diamond Scientific has installed a new cleanroom for in-house testing, research, and training.

Guest contributor B.S. Sathya Durga discusses the importance of modernizing India's pharmaceutical manufacturing industry.

This article provides an overview of solutions to address key challenges facing vaccine developers or CDMOs wishing to build their own commercial-scale mRNA production facilities.

The option of using prefilled syringes for vaccinations is not (yet) available for all types of vaccines. Stakeholders are working to expand that option while also pursuing other non-traditional routes of administration.

Automated finished product inspection has been widely adopted in the bio/pharmaceutical industry.

Automation of pharmaceutical packaging saves costs and time, say contract packagers.